outbrain
Close  

Drug charges filed vs Kerwin, Peter Lim, Peter Co, 4 more

MANILA, Philippines ֫— The National Bureau of Investigation (NBI) on Wednesday filed drug trafficking charges against alleged drug lord Kerwin Espinosa, alleged drug suppliers Peter Go Lim and Peter Co, and four others for their alleged involvement in the illegal drug trade in Cebu City.

According to the joint affidavit by agents of the NBI Task Force Against Illegal Drugs, the group “conspired in trading and trafficking ‘shabu’ (crystal meth) in Cebu City using cell phones, electronic money transfer and bank deposits, among others, from 2008 to 2011.”

ADVERTISEMENT

The affidavit added that Espinosa was consigned between 50 grams to 1 kilogram of shabu by suppliers Jeffrey “Jaguar” Diaz and Lovely Impal.

Jaguar, reportedly the top drug lord of Cebu, was killed in a police operation in Las Piñas in 2016.

FEATURED STORIES

The NBI also charged Reynaldo “Jumbo” Diaz, Jaguar’s right-hand man.  Both Jumbo and Espinosa confirmed that the main source of illegal drugs was Peter Co, the NBI said.

Jumbo is currently under the Department of Justice witness protection program.

Lovely Adam Impal, who allegedly supplied Espinosa shabu from Co, was also charged.

Also implicated was Melvin Gerpacio, who allegedly handled Espinosa’s money from the trade. Ryan Diaz, who allegedly received Espinosa’s payments from Jaguar’s shipment, was also charged.

Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS: Cebu illegal drug trade, Drug war, Kerwin Espinosa, NBI, Peter Co, Peter Lim
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.